SCHEMBL1127668

SCHEMBL1127668

CCCCCCCCCCC1CC[CH]CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.48
EPHX1 P07099 1/20 0.43
ALDH1A1 P00352 1/20 0.41
HTT P42858 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 1/20 0.37
LSS P48449 2/20 0.37
PKM P14618 1/20 0.37
SIGMAR1 Q99720 3/20 0.36
TSHR P16473 1/20 0.36
THRB P10828 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
GNAO1 P09471 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923265 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL4921924 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL27618641 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL55638 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL4921810 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL8744097 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL547742 1.00 CYP1A2 (0.48) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL27449477 0.98 CYP1A2 (0.46) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL548259 0.98 CYP1A2 (0.50) CYP1A2EPHX1ALDH1A1HTTMEN1
SCHEMBL455412 0.92 CYP1A2 (0.52) CYP1A2EPHX1ALDH1A1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118302485-A Resin composition 日产化学株式会社 2024-07-05 CN disclosed
US-12024579-B2 Curable liquid composition, particulate filler, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-02 US disclosed
EP-4382450-A1 PIGMENT COMPOSITION, COLORANT COMPOSITION, PAINT, INK, INK SET, PRINTED ARTICLE, AND PACKAGING MATERIAL artience Co., Ltd. (JP) 2024-06-12 EP disclosed
US-20240182617-A1 FLUORINE RESIN, COMPOSITION, PHOTOCROSSLINKED PRODUCT, AND ELECTRONIC DEVICE PROVIDED THEREWITH TOSOH CORPORATION (JP) 2024-06-06 US disclosed
EP-4364963-A1 TIRE Sumitomo Rubber Industries, Ltd. (JP) 2024-05-08 EP disclosed
CN-110007557-B Curable composition, film, optical film, light-emitting display element panel, and light-emitting display device 东京应化工业株式会社 2024-04-12 CN disclosed
CN-108957956-B Curable composition, cured product, cured film, display panel, and method for producing cured product 东京应化工业株式会社 2024-04-02 CN disclosed
CN-117813355-A Pigment compositions, coloring compositions, coatings, inks, ink sets, prints and packaging materials 爱天思株式会社 2024-04-02 CN disclosed
US-11926581-B2 Sulfonium salt, photoacid generator, curable composition, and resist composition SAN-APRO LIMITED (JP) 2024-03-12 US disclosed
WO-2024048522-A1 PRINTING INK SET, PRINTED MATTER, AND PACKAGING MATERIAL artience株式会社 2024-03-07 WO disclosed
EP-0781827-A1 Liquid crystal mixture and liquid crystal device comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-07-02 EP disclosed
US-5618980-A DEHYDROGENATING N-CYCLOHEXYLIDENEAMINO COMPOUND IN PRESENCE OF HYDROGEN TRANSFER CATALYST AND HYDROGEN ACCEPTOR AND ALKALI OR ALKALINE EARTH METAL COMPOUND COCATALYST MITSUI TOATSU CHEMICALS, INC. (JP) 1997-04-08 US disclosed
EP-0588060-B1 Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS (JP) 1997-04-02 EP disclosed
EP-0753505-A2 Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS, Inc. (JP) 1997-01-15 EP disclosed
US-5536878-A HYDROGEN ACCEPTOR MITSUI TOATSU CHEMICALS, INC. (JP) 1996-07-16 US disclosed
EP-0709444-A1 Liquid crystal mixture and liquid crystal device comprising the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1996-05-01 EP disclosed
EP-0669379-A1 Quinophtalone compounds and polarizing films using same MITSUI TOATSU CHEMICALS, Inc. (JP) 1995-08-30 EP disclosed
EP-0648723-A1 Diphenylacetylene compound, process for preparing the same and liquid crystal composition and element comprising the same SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1995-04-19 EP disclosed
US-5382690-A Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-01-17 US disclosed
EP-0588060-A2 Method for preparing aromatic secondary amino compound MITSUI TOATSU CHEMICALS, Inc. (JP) 1994-03-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11926581-B2 Sulfonium salt, photoacid generator, curable composition, and resist composition H1-0, SPIN1, IK CYP1A2 2160/4885EPHX1 1572/4885ALDH1A1 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.